Fin Trust Capital Advisors, LLC Exact Sciences Corp Transaction History

Fin Trust Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $65,562 - $97,489	-700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $34,971 - $46,503	-300 Reduced 30.0%	700 $92,000
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $99,610 - $142,120	1,000 New	1,000 $135,000
Q4 2019 Jan 23, 2020	SELL	$77.66 - $99.74 $1,475 - $1,895	-19 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$61.98 - $96.5 $557 - $868	-9 Reduced 32.14%	19 $2,000
Q4 2018 Feb 11, 2019	BUY	$56.04 - $82.66 $1,569 - $2,314	28 New	28 $2,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.